The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?

被引：29

作者：

Pacheco, Paulo A. F. ^{[1
]}

Faria, Robson X. ^{[1
]}

机构：

[1] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Toxoplasmose & Outras Protozooses, Rio De Janeiro, Brazil

来源：

SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 2021年 / 93卷 / 02期

关键词：

COVID-19; immunopathogenesis; NLRP3; inflammasome; SARS-CoV-2; RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; NLRP3; INFLAMMASOME; P2X(7) RECEPTOR; EXTRACELLULAR ATP; TH17; CELLS; INFECTION; PROTEIN; NEUTROPHILS; ACTIVATION;

D O I：

10.1111/sji.12960

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Coronavirus disease 2019 (COVID-19) pathogenesis remains under investigation. Growing evidence indicates the establishment of a hyperinflammatory response, characterized by sustained production of cytokines, such as IL-1 beta. The release and maturation of this cytokine are dependent on the activation of a catalytic multiprotein complex, known as "inflammasome". The most investigated is the NLRP3 inflammasome, which can be activated by various stimuli, such as the recognition of extracellular ATP by the P2X7 receptor. Based on the recent literature, we present evidence that supports the idea that the P2X7R/NLRP3 axis may be involved in the immune dysregulation caused by the SARS-CoV-2 infection.

引用

页数：9

共 90 条

[1] The P2X7 receptor: A main player in inflammation [J].

Adinolfi, Elena ;

Giuliani, Anna Lisa ;

De Marchi, Elena ;

Pegoraro, Anna ;

Orioli, Elisa ;

Di Virgilio, Francesco .

BIOCHEMICAL PHARMACOLOGY, 2018, 151 :234-244

[2] Regulation of surfactant secretion in alveolar type II cells [J].

Andreeva, Alexandra V. ;

Kutuzov, Mikhail A. ;

Voyno-Yasenetskaya, Tatyana A. .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 293 (02) :L259-L271

[3] Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza [J].

Bermejo-Martin, Jesus F. ;

Ortiz de Lejarazu, Raul ;

Pumarola, Tomas ;

Rello, Jordi ;

Almansa, Raquel ;

Ramirez, Paula ;

Martin-Loeches, Ignacio ;

Varillas, David ;

Gallegos, Maria C. ;

Seron, Carlos ;

Micheloud, Dariela ;

Manuel Gomez, Jose ;

Tenorio-Abreu, Alberto ;

Ramos, Maria J. ;

Lourdes Molina, M. ;

Huidobro, Samantha ;

Sanchez, Elia ;

Gordon, Monica ;

Fernandez, Victoria ;

del Castillo, Alberto ;

Angeles Marcos, Ma ;

Villanueva, Beatriz ;

Javier Lopez, Carlos ;

Rodriguez-Dominguez, Mario ;

Galan, Juan-Carlos ;

Canton, Rafael ;

Lietor, Aurora ;

Rojo, Silvia ;

Eiros, Jose M. ;

Hinojosa, Carmen ;

Gonzalez, Isabel ;

Torner, Nuria ;

Banner, David ;

Leon, Alberto ;

Cuesta, Pablo ;

Rowe, Thomas ;

Kelvin, David J. .

CRITICAL CARE, 2009, 13 (06)

[4] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[5]

Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443

[6] Purinergic signalling: past, present and future [J].

Burnstock, G. .

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (01) :3-8

[7] The therapeutic potential of purinergic signalling [J].

Burnstock, Geoffrey .

BIOCHEMICAL PHARMACOLOGY, 2018, 151 :157-165

[8] Extracellular ATP drives systemic inflammation, tissue damage and mortality [J].

Cauwels, A. ;

Rogge, E. ;

Vandendriessche, B. ;

Shiva, S. ;

Brouckaert, P. .

CELL DEATH & DISEASE, 2014, 5 :e1102-e1102

[9] Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome [J].

Chen, I-Yin ;

Moriyama, Miyu ;

Chang, Ming-Fu ;

Ichinohe, Takeshi .

FRONTIERS IN MICROBIOLOGY, 2019, 10

[10] Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases [J].

Chen, Yan ;

Li, Guangping ;

Liu, Ming-Lin .

GENOMICS PROTEOMICS & BIOINFORMATICS, 2018, 16 (01) :50-62

← 1 2 3 4 5 6 7 8 9 →